Cadence Pharmaceuticals clinical trials
Acquired by Keenova Therapeutics plc, Mar 19, 2014 · source ↗
The registry lists 2 studies whose lead sponsor is Cadence Pharmaceuticals. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 26, 2010.
Before and after it joined Keenova Therapeutics plc
- First submitted before Cadence Pharmaceuticals became part of Keenova Therapeutics plc
- 2
- First submitted after Cadence Pharmaceuticals became part of Keenova Therapeutics plc
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Cadence Pharmaceuticals2 studies
Something wrong with this grouping? Tell us on the Keenova Therapeutics plc page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Keenova Therapeutics plc studies →
- Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult SubjectsCompletedNCT00608959Phase 3
Sponsor listed in the registry: Cadence Pharmaceuticals · First submitted before Cadence Pharmaceuticals became part of Keenova Therapeutics plc
- Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous CathetersCompletedNCT00231153Phase 3
Sponsor listed in the registry: Cadence Pharmaceuticals · First submitted before Cadence Pharmaceuticals became part of Keenova Therapeutics plc